Inventor · disambiguated record
Bent Højgaard
Also filed as: HOEJGAARD BENT · HØJGAARD BENT
13 granted patents·5 pending applications·40 citations·filing 2000–2025
88Inventor score
Top patents by PatentIndex Score
18 records- 0185US6805880B1Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stressFERROSAN AS·Filed 2000·Granted Oct 19, 2004·26 cites·15 claims
- 0284US9579288B2Tesofensine and beta blocker combination formulationsSANIONA AS·Filed 2016·Granted Feb 28, 2017·4 cites·11 claims
- 0380US12016840B2Tesofensine and beta blocker combination formulationsSANIONA AS·Filed 2022·Granted Jun 25, 2024·0 cites·20 claims
- 0480US11819482B2Composition comprising suplatast tosilateCONRIG PHARMA APS·Filed 2018·Granted Nov 21, 2023·2 cites·20 claims
- 0580US10537551B2Tesofensine and beta blocker combination formulationsSANIONA AS·Filed 2018·Granted Jan 21, 2020·2 cites·21 claims
- 0678US10143657B2Solid oral dosage form of irinotecan for the treatment of cancerONCORAL PHARMA APS·Filed 2015·Granted Dec 4, 2018·3 cites·19 claims
- 0777US10828278B2Tesofensine and beta blocker combination formulationsSANIONA AS·Filed 2019·Granted Nov 10, 2020·1 cites·19 claims
- 0876US11975104B2Pulsatile drug delivery system for treating morning akinesiaCONTERA PHARMA AS·Filed 2017·Granted May 7, 2024·1 cites·13 claims
- 0974US2025367123A1Pulsatile drug delivery system for treating morning akinesiaCONTERA PHARMA AS·Filed 2025·Application pending·0 cites
- 1073US10231951B2Tesofensine, beta blocker combination formulationSANIONA AS·Filed 2016·Granted Mar 19, 2019·1 cites·26 claims
- 1172US11426383B2Tesofensine and beta blocker combination formulationsSANIONA AS·Filed 2020·Granted Aug 30, 2022·0 cites·17 claims
- 1269US2023114865A1Phenyl pyrrole aminoguanidine salts and formulationsSYNACT PHARMA APS·Filed 2022·Application pending·0 cites
- 1368US2023078925A1Pulsatile drug delivery system for treating morning akinesiaCONTERA PHARMA AS·Filed 2022·Application pending·0 cites
- 1451US2023051463A1Methotrexate Dosage FormROS THERAPEUTICS APS·Filed 2021·Application pending·0 cites
- 1546US2011294852A1Pharmaceutical Formulation Comprising Metformin and RepaglinideHOEJGAARD BENT·Filed 2011·Application pending·0 cites
- 1645US10456389B2Extended release nicotinamide formulationFERRING BV·Filed 2014·Granted Oct 29, 2019·0 cites·25 claims
- 1735US10912847B2Compressed solid composition for MRIAscelia Pharma AB·Filed 2020·Granted Feb 9, 2021·0 cites·18 claims
- 1831US11197828B2Solid oral dosage form of lipophilic compoundsSolural Pharma ApS·Filed 2015·Granted Dec 14, 2021·0 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →